Calidi Biotherapeutics (CLDI) Other financing activities (2022 - 2025)
Calidi Biotherapeutics (CLDI) posted quarterly Other financing activities of -$720000.0 for Q4 2025, up 43.79% year-over-year from -$500716.6 in Q4 2024, and down 199.72% quarter-over-quarter from $722000.0 in Q3 2025.
Calidi Biotherapeutics (CLDI) Other financing activities (2022 - 2025) Analysis & Trends
Calidi Biotherapeutics' Other financing activities history runs 4 years deep, the most recent figure standing at -$720000.0 for Q4 2025.
- In Q4 2025, Other financing activities rose 43.79% year-over-year to -$720000.0; the TTM figure through Dec 2025 stood at $5000.0 (up 100.64% YoY), while the FY2025 annual figure was $5000.0, down 99.68% from the prior year.
- Other financing activities for Q4 2025 stood at -$720000.0, down from $722000.0 in the prior quarter.
- The five-year high for Other financing activities was $1.3 million in Q3 2023, with the low at -$1.3 million in Q4 2024.
- The 4-year median for Other financing activities is $160000.0 (2023), against an average of $102000.0.
- The sharpest annual moves came in 2023 and 2024: Other financing activities surged 1278.57% in 2023, then tumbled 294.09% in 2024.
- Calidi Biotherapeutics' Other financing activities stood at -$56000.0 in 2022, then soared by 1278.57% to $660000.0 in 2023, then sank by 294.09% to -$1.3 million in 2024, then surged by 43.79% to -$720000.0 in 2025.
- Business Quant data shows CLDI's Other financing activities at -$720000.0 in Q4 2025, $722000.0 in Q3 2025, and -$298000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -720,000.00 |
| Dec 31, 2025 | -720,000.00 |
| Sep 30, 2025 | 722,000.00 |
| Sep 30, 2025 | 722,000.00 |
| Jun 30, 2025 | -298,000.00 |
| Jun 30, 2025 | -298,000.00 |
| Mar 31, 2025 | 301,000.00 |
| Mar 31, 2025 | 301,000.00 |
| Dec 31, 2024 | -1.28 Mn |
| Dec 31, 2024 | -1.28 Mn |
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | -160,000.00 |
| Jun 30, 2024 | -160,000.00 |
| Mar 31, 2024 | 162,000.00 |
| Mar 31, 2024 | 162,000.00 |
| Dec 31, 2023 | 660,000.00 |
| Dec 31, 2023 | 660,000.00 |
| Sep 30, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.27 Mn |